Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016

Prevalence and Outcomes of Non-alcoholic Fatty Liver Disease (NAFLD) among Asian American Adults in the United States

(2019) Pegah Golabi et al.   LIVER INTERNATIONAL

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016

(2019) Donghee Kim et al.   Hepatology International

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy

(2018) Jobert Richie Nansseu et al.   EPIDEMIOLOGY

Metabolic syndrome in human immunodeficiency virus-infected patients

(2018) M Duro et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)

(2018) Pegah Golabi et al.   MEDICINE

Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection

(2018) Cameron Sikavi et al.   DIGESTIVE DISEASES AND SCIENCES

HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients

(2018) D Salmon-Ceron et al.   HEPATOLOGY

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

(2017) Chris Estes et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

(2017) Adam Trickey et al.   Lancet HIV

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

(2017) Michael H. Le et al.   PLoS One

Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines

(2016) Ricardo Moure et al.   ANTIVIRAL RESEARCH

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Advances in the management of HIV/HCV coinfection

(2016) Mattias Mandorfer et al.   Hepatology International

Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy

(2016) L Milazzo et al.   HIV MEDICINE

Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals

(2016) Melissa Herrin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

(2015) AC Achhra et al.   HIV MEDICINE

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

(2015) Zobair M. Younossi et al.   JOURNAL OF INFECTIOUS DISEASES

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

(2015) Jean-Michel Molina et al.   LANCET

Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey

(2014) C. E. Ruhl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome

(2014) Paula Freitas et al.   BMC INFECTIOUS DISEASES

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

(2014) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidative stress in HIV-1 infected patients

(2014) Helena K. Morimoto et al.   NUTRITION

Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management

(2014) Wen Kang et al.   Expert Review of Gastroenterology & Hepatology

Liver Disease in the HIV–Infected Individual

(2010) Jennifer C. Price et al.   Clinical Gastroenterology and Hepatology

Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007†

(2010) P. R. Spradling et al.   JOURNAL OF VIRAL HEPATITIS

Assessing Validity of ICD-9-CM and ICD-10 Administrative Data in Recording Clinical Conditions in a Unique Dually Coded Database

(2008) Hude Quan et al.   HEALTH SERVICES RESEARCH

Relationship of Fat Distribution with Adipokines in Human Immunodeficiency Virus Infection

(2007) Lisa A. Kosmiski et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM